Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02244 (Long intergenic non-protein coding RNA 2244) is a member of the lincRNA family, a group of long non-coding RNAs situated between protein-coding genes. These molecules do not encode proteins and instead function in various regulatory capacities within the cell, such as modulating chromatin architecture, stabilizing transcripts, and regulating gene expression, often with highly specific tissue expression patterns[1][3][5]. LINC02244 is annotated in major genomic resources, but as of current knowledge, it has no defined role in specific pathways, diseases, or as a protein target. Its prominence is as an example of emerging functional non-coding elements in the genome, with roles that may include enhancer-like or regulatory activities affecting local gene expression[5]. No evidence supports its use as a receptor, enzyme, biomarker, or drug target in medical or pharmacological contexts. Summary of Key Points: - LINC02244 is a long intergenic non-coding RNA without known protein coding function, drug interactions, or biomarker status. - It is not recognized as a therapeutic target or risk for safety concerns. - Its general biological role falls within chromatin architecture modulation and gene expression regulation, consistent with the lincRNA family definition[5].
Not applicable. LINC02244 is not targeted directly by drugs for mechanism-based action. General lincRNA mechanisms include acting as enhancers, scaffolds, or decoys in chromatin and transcriptional regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2244 (LINC02244).